Quarterly report · Q3
7090.TEDINET S100Q55F
Period2022-04-01 → 2022-12-31
Filed2023-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.0bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥3.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.5bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | −¥463m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥196m | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | −¥477m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥151m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥189m | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | −¥478m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥157m | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥389m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥72m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥97m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥390m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥97m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥3.9bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥3.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥3.1bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.1bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥2.1bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥738m | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.2bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.4bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-277.31 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-88.3 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.64 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥69.09 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.79 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥50.55 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥67.47 | 2021-04-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 19.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.3% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E33790-000Financial Services Segmentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥562m |
| jpcrp040300-q3r_E33790-000Financial Services Segmentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥562m |
| jpcrp040300-q3r_E33790-000Financial Services Segmentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥77m |
| jpcrp040300-q3r_E33790-000Osteopathic Solution Segmentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E33790-000Osteopathic Solution Segmentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E33790-000Osteopathic Solution Segmentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥387m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥2.0bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥2.0bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | −¥463m |
| jpcrp040300-q3r_E33790-000Financial Services Segmentsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥691m |
| jpcrp040300-q3r_E33790-000Financial Services Segmentsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥691m |
| jpcrp040300-q3r_E33790-000Financial Services Segmentsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥14m |
| jpcrp040300-q3r_E33790-000Osteopathic Solution Segmentsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥1.8bn |
| jpcrp040300-q3r_E33790-000Osteopathic Solution Segmentsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥1.8bn |
| jpcrp040300-q3r_E33790-000Osteopathic Solution Segmentsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥182m |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥2.5bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥2.5bn |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥196m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 359
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |